Menu

Methylcellulose

Also known as: Methyl cellulose, E461

A cellulose-derived thickener and bulk-forming laxative ingredient with product-specific hydration warnings and limited chronic-constipation trial evidence.

A layered-vellum collage of a translucent gel fold beside a textured cream-paper strip.
Editorial illustration

Methylcellulose is a modified cellulose used in foods and some bulk-forming laxatives. A current U.S. label includes relief of occasional constipation, with an important full-glass-fluid warning. The 2023 AGA/ACG chronic idiopathic constipation guideline found no eligible methylcellulose trials in its evidence review, leaving the strength of evidence for that chronic condition uncertain.2, 3

  • U.S. food rules specify methylcellulose identity and permit use under good manufacturing practice.1
  • The cited powder label provides 2 g of active methylcellulose per labeled dose. The total powder weight differs between its formulations.2
  • The AGA/ACG guideline's conditional fiber recommendation had low certainty and did not include eligible methylcellulose trials.3

What is Methylcellulose?

The food-additive designation E461 identifies methylcellulose. Related cellulose derivatives have different identities and uses. This guide follows methylcellulose itself across food specifications and one labeled oral laxative formulation, while keeping each source's purpose clear.1, 4

Where it comes from

Natural sources

  • Based on cellulose, a plant structural polysaccharide.

How it's made

Chemical modification yields methylcellulose. The E461 identity distinguishes it from the other cellulose derivatives assessed alongside it.

What it does in products

  • Thickening and texture control in foods
  • Bulk-forming laxative active in labeled oral products

Benefits

Chronic-constipation evidence has a specific gap

insufficient evidence

A labeled occasional-constipation use and a systematic chronic-condition evidence review provide different information.2, 3

The cited DailyMed product identifies methylcellulose as a bulk-forming laxative. In the 2023 AGA/ACG review, no methylcellulose studies met eligibility for chronic idiopathic constipation. This leaves efficacy for that condition uncertain within the review, rather than proving ineffectiveness in every setting.

Evidence scope and limitations

Methylcellulose food identity, the current cited U.S. powder laxative label, the 2023 AGA/ACG adult chronic idiopathic constipation guideline and EFSA's final cellulose food-additive assessment.

  • A lack of eligible trials in one guideline does not mean the ingredient has never been studied or is ineffective in every population.
  • The label describes a particular product and occasional-constipation use. Its scoop, warnings and age directions should not be generalized across formulations.
  • The food-additive safety review does not establish chronic laxative efficacy, a personalized dose or a complete medicine-interaction profile.

Evidence last checked: 2026-11-12

Side effects & safety

Choking or obstruction if taken with insufficient fluid (varies)The label warns that the product may swell and block the throat or esophagus. It requires a full glass of fluid and advises against use in people with swallowing difficulty.

Safety considerations

  • This label and the guideline do not constitute a complete drug-interaction assessment. A pharmacist can check a specific medicine schedule and formulation.
  • Not for: Do not use the cited product if you have difficulty swallowing. Seek immediate help for chest pain, vomiting, or difficulty swallowing or breathing after taking it.
  • Not for: The label directs professional advice for abdominal pain, nausea, vomiting or a sudden bowel-habit change lasting two weeks. Stop and seek advice for rectal bleeding, no bowel movement after use, or a need for laxatives beyond seven days.
2, 3

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

In bulk-forming laxative products

The cited adult product directions use 2 g active methylcellulose per labeled dose with at least 8 oz of water or other fluid. This describes that product, not 2 g of every flavored powder. Scoop directions and total powder weights differ between its orange and sugar-free versions. Follow the exact label and never swallow the powder dry.

2

Regulatory status

  • 21 CFR 182.1480 recognizes specified methylcellulose for food use under good manufacturing practice. DailyMed separately hosts the cited OTC laxative label. Food GRAS status and a label listing do not themselves establish FDA approval of a therapeutic product.
  • GRAS (generally recognized as safe) for food use.
1, 2

Why a general fiber recommendation is incomplete

The AGA/ACG panel suggested fiber for chronic idiopathic constipation with low-certainty evidence. The eligible fiber studies differed by ingredient, and methylcellulose had no eligible studies. Applying a class-wide recommendation to a particular product would conceal that gap.

EFSA's 2018 review addressed food-additive safety for a group of celluloses, including E461. It is useful for the food-use safety question, while an occasional-constipation label supplies product-specific directions and warnings. Neither source fills the missing chronic-condition trial evidence.

3, 4, 2

Frequently asked questions

Does every methylcellulose powder use the same scoop?

No. The cited orange and sugar-free versions contain different total powder weights for the same 2 g of active ingredient. Use the directions on the exact formulation, including its full-glass-fluid requirement.2

The bottom line

Check the exact formulation and hydration instructions, and keep the chronic-constipation evidence gap visible.

References

  1. 21 CFR 182.1480: Methylcellulose. Electronic Code of Federal Regulations · government guidance · Current USP identity and food-use GMP conditions checked November 12, 2026; not the historical proposed rule
  2. Citrucel — methylcellulose powder, for solution. Haleon US Holdings LLC / DailyMed (2026) · ingredient monograph · SPL set ID 9d5f2244-a610-4d45-b6e8-e79bb17a558f, version 17; updated March 18, 2026; formulation-specific label, not a product endorsement
  3. Chang L, Chey WD, Imdad A, et al.. American Gastroenterological Association–American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. American Journal of Gastroenterology (2023) · clinical guideline · DOI 10.14309/ajg.0000000000002227; 118(6):936–954; full-text fiber evidence review checked
  4. EFSA Panel on Food Additives and Nutrient Sources added to Food. Re-evaluation of celluloses E 460(i), E 460(ii), E 461, E 462, E 463, E 464, E 465, E 466, E 468 and E 469 as food additives. EFSA Journal (2018) · safety assessment · DOI 10.2903/j.efsa.2018.5047; final opinion published January 16, 2018, adopted September 27, 2017; food-additive scope

Revision history

  1. Initial AI-assisted source compilation with claim-level citations, formulation distinctions and explicit evidence limitations; not independent medical review.